U.S. diabetes patients face delays as insurers tighten ozone coverage

U.S. diabetes patients face delays as insurers tighten ozone coverage

Dec 12 (Reuters) – Some patients with type 2 diabetes say they are having greater difficulty getting reimbursed for drugs like Ozempic as U.S. insurers impose restrictions aimed at preventing …

Read more